Nabriva Therapeutics (FRA:NTY) Inventory Turnover : 0.99 (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Nabriva Therapeutics Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Nabriva Therapeutics's Cost of Goods Sold for the three months ended in Jun. 2023 was €8.38 Mil. Nabriva Therapeutics's Average Total Inventories for the quarter that ended in Jun. 2023 was €8.43 Mil. Nabriva Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.99.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Nabriva Therapeutics's Days Inventory for the three months ended in Jun. 2023 was 91.85.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nabriva Therapeutics's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 3.55.

Nabriva Therapeutics Inventory Turnover Historical Data

The historical data trend for Nabriva Therapeutics's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nabriva Therapeutics Inventory Turnover Chart

Nabriva Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Inventory Turnover

Get a 7-Day Free Trial

0.10

0.23

1.32

2.46

Nabriva Therapeutics Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Inventory Turnover	Get a 7-Day Free Trial															0.29	0.28	1.16	0.47	0.99

Nabriva Therapeutics Inventory Turnover Calculation

Nabriva Therapeutics's Inventory Turnover for the fiscal year that ended in Dec. 2022 is calculated as

	Inventory Turnover (A: Dec. 2022 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2022 )	/ (	(Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )
=	26.981	/ (	(12.84	+	9.134)	/	2 )
=	26.981	/	10.987
=	2.46

Nabriva Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

	Inventory Turnover (Q: Jun. 2023 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Jun. 2023 )	/ (	(Total Inventories (Q: Mar. 2023 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )
=	8.376	/ (	(8.431	+	0)	/	1 )
=	8.376	/	8.431
=	0.99

Nabriva Therapeutics (FRA:NTY) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nabriva Therapeutics's Days Inventory for the three months ended in Jun. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2023 )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
	=	8.431	/	8.376	*	365 / 4
	=	91.85

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nabriva Therapeutics's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	8.431	/	2.376
	=	3.55

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Nabriva Therapeutics Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Nabriva Therapeutics's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Nabriva Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nabriva Therapeutics PLC (FRA:NTY) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

NBRVF:USA

Address

Alexandra House, Office 225/227, The Sweepstakes, Dublin, IRL, 4

Website

https://www.nabriva.com

Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company has developed a product candidate, XENLETA, a semi-synthetic pleuromutilin antibiotic that is the first in its class for oral and IV administration in humans. XENLETA is designed to inhibit the synthesis of a specific protein on the bacterial ribosome. It operates in one reportable segment, which comprises the research and development of novel anti-infective agents to treat serious infections. The firm has commercial rights to two approved products, SIVEXTRO and XENLETA, as well as one development product candidate, CONTEPO.

Nabriva Therapeutics Headlines

No Headlines